Detalles de la búsqueda
1.
Fundamental principles of epidemic spread highlight the immediate need forlarge-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20042291
2.
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21254128
3.
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune pathways related to tissue injury
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-449178
4.
Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20247841
5.
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264916
6.
Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-500063
7.
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22279558
8.
A gene locus that controls expression of ACE2 in virus infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20080408
9.
Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naive and convalescent healthcare workers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270447
10.
Implementation and extended evaluation of the Euroimmun Anti-SARS-CoV-2 IgG assay and its contribution to the United Kingdom's COVID-19 public health response
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265497
11.
Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277368
12.
Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20060467
13.
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265651
14.
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-492554
15.
SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20105486
16.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-134551
17.
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256571
18.
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20205054
19.
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20205831
20.
Genetic mechanisms of critical illness in Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20200048